Novel peptide & mitochondrial signaling
Track new mechanistic papers, first-in-human studies, trial registrations and analytical standards as they appear.
Humanin / HNGSHLP familyARA-290B7-33
Research Rebel / Emerging Research
EMERGING RESEARCH
Track what is new without confusing novelty with evidence.
A radar for developing compounds, mechanisms, source maturity, and unanswered questions.
EMERGING RESEARCH
The watchlist for what's next.
A structured place for early compounds, new papers, analytical methods and regulatory changes—without turning novelty into hype.
Testing methods
New LC-MS, impurity characterization, reference materials and validation approaches.
Status changes
FDA discussions, safety assessments and changes that affect how evidence should be described.
DISCOVERED
New report or compound enters the watchlist.
TRIAGED
Source quality and novelty are checked.
DOSSIERED
Evidence layers and limitations are organized.
UPDATED
New evidence changes the record—not the old hype.
EMERGING COMPOUND RADAR
Novelty gets a status—not a hype score.
DETECTEDWATCHINGLITERATURE FOUNDHUMAN RESEARCHDOSSIER PUBLISHED
Humanin / HNGLITERATURE FOUND
SHLP familyWATCHING
B7-33LITERATURE FOUND
KLOTHO-derived peptidesWATCHING
EVIDENCE MATURITY
New is a timeline position—not a quality score.
Signal detected
A molecule, mechanism, preprint, patent, or early paper is worth watching, but conclusions remain highly provisional.
Independent evidence accumulating
Replication, stronger models, registered studies, analytical standards, or human data begin to reduce uncertainty.
Evidence can be mapped
Research Rebel organizes supportive findings, contradictory findings, limitations, regulatory context, and unanswered questions without turning maturity into endorsement.